It is a pharma public limited company based in Bangalore, Karnataka, India, established in 2021.
2021 | Bangalore, Karnataka, India | ActiveAcurela Pharms Limited, a active public limited company, was established on 20 July 2021 in Bangalore, Karnataka, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24290KA2021PLC149702. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.50 M.
Employing 27 professional, Its leadership includes Shivapura Bhadraiah Gangadhar (Director), Latha Gangadhar (Director), Thushar Shivapura Gangadhar (Managing Director). Past directors included Chinnappa Ramakrishna Shankar, Thushar Shivapura Gangadhar. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at #1335, 3Rd Cross, M R H B Colony Vijaynagar, Bangalore, Karnataka, 560079.
U24290KA2021PLC149702
149702
20 July 2021
₹1.00 M
₹0.50 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Acurela Pharms Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shivapura Bhadraiah Gangadhar | Director | 20 Jul 2021 | Current |
| Latha Gangadhar | Director | 01 Nov 2024 | Current |
| Thushar Shivapura Gangadhar | Managing Director | 20 Jul 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 08 Nov 2024 | Past |
| Pramod Abcsdd | Director | 09 Oct 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Acurela Pharms Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 263.02% increase. The company also saw a substantial fall in profitability, with a 275.91% decrease in profit. The company's net worth observed a substantial decline by a decrease of 576.82%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Acurela Pharms had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Acurela Pharms has a workforce of 27 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Acurela Pharms, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Acurela Pharms's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latha Gangadhar was appointed as a Director was appointed as a Director on 01 Nov 2024 & has been associated with this company since 1 year 2 months . was recorded as a recent event.
The activity Acurela Pharms Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Acurela Pharms Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was recorded as a recent event.
Progress on Shivapura Bhadraiah Gangadhar was appointed as a Director was appointed as a Director on 20 Jul 2021 & has been associated with this company since 4 years 5 months . was documented.
Progress on Thushar Shivapura Gangadhar was appointed as a Managing Director was appointed as a Managing Director on 20 Jul 2021 & has been associated with this company since 4 years 5 months . was documented.
The activity Acurela Pharms Limited was registered on 20 Jul 2021 with Roc Bangalore & aged 4 years 5 months as per MCA records. was completed.
The CIN of Acurela Pharms Limited is U24290KA2021PLC149702.
Acurela Pharms Limited is headquartered at #1335, 3Rd Cross, M R H B Colony Vijaynagar, Bangalore, Karnataka, 560079.
Acurela Pharms Limited was incorporated on 20 July 2021.
The current directors of Acurela Pharms Limited are
The primary industry of Acurela Pharms Limited is Trade.
Acurela Pharms Limited is unlisted.
The authorized capital of Acurela Pharms Limited is ₹1.00 M, and the paid-up capital is ₹0.50 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX